Trial intelligence / Profile preview

Rupiprostone for diabetic constipation

ChiCTR2400083154Phase 4Not yet recruiting

Sponsor
Binzhou Medical University Hospital
Start
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of lubiprostone in constipation (3 arms), sponsored by Binzhou Medical University Hospital. Primary endpoints: Number of spontaneous bowel movements before and after treatment, Effective results of colonic transport experiments before and after treatment and 7 more. Planned start Apr 2024; status: not yet recruiting.

02

Drugs

lubiprostone
03

Conditions

constipation

Beyond the preview

Go deeper on ChiCTR2400083154.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400083154.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call